Showing 21 - 40 of 63 results
This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.
The Biological Small Angle X-ray Scattering beamline will be optimised for measuring small angle scattering of surfactants, nanoparticles, polymers, lipids, proteins and other biological macromolecules in solution. BioSAXS combines combine a state-of-the-art high-flux small angle scattering beamline with specialised in-line protein purification and preparation techniques for high-throughput protein analysis.
Commitment to undertake health research.
The ANSTO Awards in Nuclear Science and Technology 2018 were presented on Friday 2 November at The Australian Museum, and showcased ANSTO’s unique nuclear science and technology capabilities, which enable progress in the key areas of health research and innovation for industry.
On the 9th of December 2022, the Minister for Industry, Science and Technology provided his Statement of Expectations to ANSTO.
Congress marks watershed moment for nuclear medicine and ANSTO
ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.
Choose from our list of research topics and let your students lead a 30 minute Q&A session with our ANSTO experts.
The NSW Government will invest $12.5 million to support the expansion of the Innovation Precinct at the Lucas Heights campus of the Australian Nuclear Science and Technology Organisation (ANSTO).
The final report on the safety of Building 23 by the independent expert review team has been completed.
This month ANSTO is opening its doors to 11 talented young people from across Australia as the two-year Graduate Program kickstarts.
In 2023 we’re celebrating the 70th Anniversary since Australia began developing our nation’s Australia’s nuclear capabilities.
Developed by ANSTO’s predecessor the Australian Atomic Energy Commission (known as the AAEC) in the late 1960s, the Technetium-99m Generator revolutionised nuclear medicine imaging in Australia by enabling imaging procedures to be performed not only in major capital cities but throughout regional and rural Australia.
In May 2023, The Honourable Dr Annabelle Bennett, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry, Science and Technology.
Latest information on the scheduled supply of our nuclear medicine production.
ANSTO recognises local Indigenous heritage in new mural